Common arm comparative outcomes analysis of phase 3 trials of cisplatin + irinotecan versus cisplatin + etoposide in extensive stage small cell lung cancer 1: Final patient-level results from Japan Clinical Oncology Group 9511 and Southwest oncology group 0124

Primo N Lara, Kari Chansky, Taro Shibata, Haruhiko Fukuda, Tomohide Tamura, John Crowley, Mary W. Redman, Ronald Natale, Nagahiro Saijo, David R Gandara

Research output: Contribution to journalArticlepeer-review

46 Scopus citations

Fingerprint

Dive into the research topics of 'Common arm comparative outcomes analysis of phase 3 trials of cisplatin + irinotecan versus cisplatin + etoposide in extensive stage small cell lung cancer 1: Final patient-level results from Japan Clinical Oncology Group 9511 and Southwest oncology group 0124'. Together they form a unique fingerprint.

Medicine & Life Sciences